Press "Enter" to skip to content

FDA approves chemoimmunotherapy regimen in diffuse large B-cell lymphoma – The Cancer Letter Publications

admin 0

FDA approves chemoimmunotherapy regimen in diffuse large B-cell lymphoma  The Cancer Letter Publications

FDA granted accelerated approval to Polivy (polatuzumab vedotin-piiq), a novel antibody-drug conjugate, in combination with the chemotherapy bendamustine …

“cervical cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *